One of the HPV vaccines available in Canada has now been approved for use by boys and men.
Merck announced Tuesday that Health Canada has approved its vaccine Gardasil for use in boys and men aged nine through 26.
The vaccine is designed to prevent infection from the HPV strains that can cause genital warts (types 6 and 11). It can also protect against HPV types 16 and 18 which, when sexually transmitted...
SAN FRANCISCO -- February 22, 2010 -- Researchers said here during the 17th Conference on Retroviruses and Opportunistic Infections (CROI) that they could not find a link between most cancers and a diagnosis of AIDS.
During a poster presentation Meredith Shiels, PhD, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, said the researchers did not find a connection between...
Starting HAART With High CD4 Counts Reduces Incidence of Squamous Cell Anal Cancer: Presented at CROI
Doctor's Guide
DGDispatch
By Ed Susman
SAN FRANCISCO -- February 22, 2010 -- Patients with HIV who begin antiretroviral therapy before their CD4-positive cell counts drop below 200 cells/mm3 appear to have significantly reduced risk of developing squamous cell cancer of the anus, researchers said here at the 17th Conference on Retroviruses and Opportunistic...
Canadian women have a choice of two vaccines against HPV, the family of viruses that can cause cervical cancer, now that Health Canada has approved GlaxoSmithKline's vaccine, Cervarix.
The vaccine, which is expected to be available by the end of the month, will compete against Gardasil, a product of Merck Canada, which has been on the Canadian market since 2006.
Medical News Today
Article Date: 09 Oct 2009 - 0:00 PDT
New research published on bmj.com today reports that if boys were included in human papillomavirus (HPV) vaccination programs of pre-adolescent girls, it would not be cost-effective. It is probable that the costs of vaccinating boys will outweigh the added health benefits.
It has been consistently exposed in prior studies that HPV vaccination of pre-adolescent (12 year-old) girls provides good value for money....
